Design, synthesis and evaluation of novel ferulic acid derivatives as multi-target-directed ligands for the treatment of Alzheimer’s disease
- 1 January 2020
- journal article
- research article
- Published by Elsevier in Bioorganic Chemistry
- Vol. 94, 103413
Abstract
No abstract availableKeywords
Funding Information
- National Major Science and Technology Projects of China
This publication has 42 references indexed in Scilit:
- Alzheimer Mechanisms and Therapeutic StrategiesCell, 2012
- Current and Emerging Drug Treatment Options for Alzheimerʼs DiseaseDrugs, 2011
- Recent advances in the multitarget‐directed ligands approach for the treatment of Alzheimer's diseaseMedicinal Research Reviews, 2011
- Beneficial Catalytic Immunity to Aβ PeptideRejuvenation Research, 2010
- Oxidative Stress in the Progression of Alzheimer Disease in the Frontal CortexJournal of Neuropathology & Experimental Neurology, 2010
- Clozapine protects PC-12 cells from death due to oxidative stress induced by hydrogen peroxide via a cell-type specific mechanism involving inhibition of extracellular signal-regulated kinase phosphorylationBrain Research, 2009
- Neurobiology of butyrylcholinesteraseNature Reviews Neuroscience, 2003
- The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to TherapeuticsScience, 2002
- Rivastigmine, a brain-region selective acetylcholinesterase inhibitor for treating Alzheimer’s disease: review and current statusExpert Opinion on Investigational Drugs, 1999
- Factors Influencing the Antioxidant Activity Determined by the ABTS•+Radical Cation AssayFree Radical Research, 1997